Skip to main content
NIH funding notice PA-18-718

Accelerating Basic and Translational Research in Hidradenitis Suppurativa (R21 Clinical Trial Not Allowed)

Closed on September 7, 2021.

Posted
March 28, 2018
Close date
September 7, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $573,001 in first-year total cost, median $200,640.

Most frequent study sections

  1. Arthritis, Connective Tissue and Skin Study Section[ACTS]2
  2. Genetics of Health and Disease Study Section[GHD]1

Most frequent institutions

  1. HENRY FORD HEALTH SYSTEM1
  2. MASSACHUSETTS GENERAL HOSPITAL1
  3. UNIV OF NORTH CAROLINA CHAPEL HILL1
Competing awards under PA-18-718 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2022Genetic risk of hidradenitis suppurativa in African Americans1R21AR079089-01A1ADRIANTO, INDRAMI, QING-SHENGHENRY FORD HEALTH SYSTEM, MI$200,640ACTS
2020Identification of genetic loci and pathways underlying hidradenitis suppurativa risk1R21AR076009-01A1ASGARI, MARYAM MANDANACHOQUET, HELENEMASSACHUSETTS GENERAL HOSPITAL, MA$203,401GHD
2020Evaluation of the Genetics of Hidradenitis Suppurativa1R21AR075996-01A1LI, YUNMOHLKE, KAREN L.SAYED, CHRISTOPHER JUNIV OF NORTH CAROLINA CHAPEL HILL, NC$168,960ACTS

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PA-18-718: Accelerating Basic and Translational Research in Hidradenitis Suppurativa (R21 Clinical Trial Not Allowed) | ScienceDex | ConductScience